A multinational drugmaker is paying 45 states including South Dakota $105 million to settle complaints that the company unlawfully marketed three drugs.
South Dakota Attorney General Marty Jackley says South Dakota's share of the settlement is nearly $1.2 million.
The settlement resolves allegations that London-based Glaxo illegally marketed Advair, Paxil and Wellbutrin for purposes that had not been approved by the Food and Drug Administration. Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote that drug for an unapproved use, a practice called off-label marketing.
The asthma treatment Advair is Glaxo's best-selling product. Paxil and Wellbutrin are antidepressant drugs.
Most Popular Today
New Hotel Coming To Southwest Sioux Falls
Riverboat Casino Ends Operation In Sioux City
Hard Rock Casino Opens In Sioux City
- 4.Your Money Matters
Hiring A Roofer
HJN Realtor Breaks Off To Form Own Agency
Sioux Falls On Track To Break Record Year For Construction
Hard Rock Hotel & Casino Opens In Sioux City Friday
- 8.Your Money Matters
Fix The Car Or Cash The Check?
Friday Morning Business Brief
Thursday Morning Business Brief